Homepage | Forward to a Friend | Make a Donation |
|
eLetter #950 | December 31, 2021 |
|
|
Happy New Year!
Feliz Año Nuevo • Bonne Année • Gelukkig Nieuwjaar • Frohes Neues Jahr • Eftychisméno To Néo Étos • Hauʻoli Makahiki Hou • Xīnnián Kuàilè • Navavarsh Kee Shubhakaamana • Athbhliain Faoi Mhaise Daoibh • Felice Anno Nuovo • Akemashiteomedetōgozaimasu • Shnorhavor Nor Tari
Please note that the Scleroderma Foundation's national office is closed in observance of the New Year holiday and will reopen Monday, January 3. Calls to (800) 722-4673 and emails to Sfinfo@scleroderma.org will be answered on Monday, January 3. In the meantime, please visit our website and social media accounts to stay informed and engaged with your scleroderma family.
SCLERODERMA.ORG
|
|
Exciting Changes Ahead
With a new year on the way, the Scleroderma Foundation is rededicating itself to our common mission to advance medical research, promote disease awareness, and provide support and education to people with scleroderma, their families, and support networks. No matter what form of scleroderma you have, or where you, your loved one, or your child are in your scleroderma journey, we are here to help you find your best path.
To fulfill that promise, we are prepared to grow, to build a foundation for the future. Shortly after the new year, look for something new from us that we believe captures the national breadth of our community and the hopeful connections we make. We're excited about the changes ahead and we hope that you are too.
|
|
Strategic Plan Update
ZOOM: January 13, 2022; 2 PM Eastern
Join CEO Mary J. Wheatley to hear an update on the Foundation's strategic plan. Learn about progress in our exciting work to strengthen our organization and to build capacity for growth in support of individuals affected by scleroderma, to expand our education programs, and to build greater resources for research funding.
REGISTER
|
|
Curing Scleroderma
Curing scleroderma starts with each one of us. Will you help accelerate the Scleroderma Foundation's progress toward finding a cure? Go to scleroderma.org/winter to make a year-end, tax-deductible gift. Give by December 31 to take advantage of the CARES Act tax incentives that will expire this year
Disclaimer: The Scleroderma Foundation does not provide financial or tax advising. Please speak with your financial advisor about the impact your charitable giving will have.
|
|
BIPOC Scleroderma Support Group
ZOOM: January 16, 2022; 4 - 5 PM Eastern
Join our facilitators, Christy, Demi, Demetra, Erion, Eva, Marilyn, and Sy, for a discussion on economic disparities and resources that may help you navigate your scleroderma journey.
After registering, you will receive a confirmation email containing information about joining the meeting.
REGISTER
|
|
Deadlines for 2022 Health Insurance
You can still enroll in or change 2022 Marketplace health insurance right now on HealthCare.gov.
If you enroll or change a current plan by January 15, 2022, coverage will start February 1, 2022. After January 15, you can only enroll or change plans if you qualify for a Special Enrollment Period.
HEALTHCARE.GOV
|
|
Scleroderma and the Lungs
VIDEO: Recorded July 2021
Watch this presentation on scleroderma and the lungs by Kristin B. Highland, MD, MDSCR, recorded during the 2021 virtual National Scleroderma Conference. The lungs are potentially affected in all individuals who have systemic scleroderma. Individuals living with systemic scleroderma need to know how they can be proactive in helping the doctors identify any lung involvement as early as possible. There have been many exciting advances in the treatment of pulmonary fibrosis and pulmonary hypertension. This presentation reviews important complications of scleroderma and new treatments available.
WATCH
|
|
Research Updates: Juvenile Systemic Sclerosis
VIDEO: Recorded October 2021
Watch this presentation from the 2021 virtual Kids Get Scleroderma, Too! conference with Kathryn Torok, MD, of the Children's Hospital of Pittsburgh, University of Pittsburgh, Pediatric Scleroderma Center. Dr. Torok presents the latest information regarding research advances in juvenile systemic sclerosis.
WATCH
|
Advertisement |
|
Advertisement |
|
|
|
|
|
|
Disclaimer: The Scleroderma Foundation in no way
endorses any drugs, treatments, clinical trials, or studies reported in the eLetter. Information is
provided to keep the readers informed. Because the manifestations and severity of scleroderma vary among individuals, personalized medical management is essential. Therefore, it is strongly recommended that all drugs and treatments be discussed with the reader’s physician(s) for proper evaluation and treatment.
|
|
|